Literature DB >> 21649645

Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

James Barwell1, Joseph J Gingell, Harriet A Watkins, Julia K Archbold, David R Poyner, Debbie L Hay.   

Abstract

The calcitonin receptor (CTR) and calcitonin receptor-like receptor (CLR) are two of the 15 human family B (or Secretin-like) GPCRs. CTR and CLR are of considerable biological interest as their pharmacology is moulded by interactions with receptor activity-modifying proteins. They also have therapeutic relevance for many conditions, such as osteoporosis, diabetes, obesity, lymphatic insufficiency, migraine and cardiovascular disease. In light of recent advances in understanding ligand docking and receptor activation in both the family as a whole and in CLR and CTR specifically, this review reflects how applicable general family B GPCR themes are to these two idiosyncratic receptors. We review the main functional domains of the receptors; the N-terminal extracellular domain, the juxtamembrane domain and ligand interface, the transmembrane domain and the intracellular C-terminal domain. Structural and functional findings from the CLR and CTR along with other family B GPCRs are critically appraised to gain insight into how these domains may function. The ability for CTR and CLR to interact with receptor activity-modifying proteins adds another level of sophistication to these receptor systems but means careful consideration is needed when trying to apply generic GPCR principles. This review encapsulates current thinking in the realm of family B GPCR research by highlighting both conflicting and recurring themes and how such findings relate to two unusual but important receptors, CTR and CLR.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21649645      PMCID: PMC3415637          DOI: 10.1111/j.1476-5381.2011.01525.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  109 in total

1.  High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening.

Authors:  Caterina Bissantz; Antoine Logean; Didier Rognan
Journal:  J Chem Inf Comput Sci       Date:  2004 May-Jun

2.  Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor.

Authors:  Maoqing Dong; Delia I Pinon; Richard F Cox; Laurence J Miller
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

3.  A structural basis for sequence comparisons. An evaluation of scoring methodologies.

Authors:  M S Johnson; J P Overington
Journal:  J Mol Biol       Date:  1993-10-20       Impact factor: 5.469

4.  GCRDb: a G-protein-coupled receptor database.

Authors:  L F Kolakowski
Journal:  Receptors Channels       Date:  1994

5.  Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity.

Authors:  D M Findlay; S Houssami; H Y Lin; D E Myers; C L Brady; P K Darcy; K Ikeda; T J Martin; P M Sexton
Journal:  Mol Endocrinol       Date:  1994-12

6.  Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.

Authors:  Lars M Ittner; Felix Luessi; Daniela Koller; Walter Born; Jan A Fischer; Roman Muff
Journal:  Biochem Biophys Res Commun       Date:  2004-07-09       Impact factor: 3.575

7.  Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor.

Authors:  Robert C Gensure; Naoto Shimizu; Janet Tsang; Thomas J Gardella
Journal:  Mol Endocrinol       Date:  2003-08-28

8.  Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues.

Authors:  Rakel López de Maturana; Janet Treece-Birch; Fatima Abidi; John B C Findlay; Dan Donnelly
Journal:  Protein Pept Lett       Date:  2004-02       Impact factor: 1.890

9.  Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.

Authors:  Jaesook Roh; Chia Lin Chang; Alka Bhalla; Cynthia Klein; Sheau Yu Teddy Hsu
Journal:  J Biol Chem       Date:  2003-11-13       Impact factor: 5.157

10.  Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor.

Authors:  Maoqing Dong; Delia I Pinon; Richard F Cox; Laurence J Miller
Journal:  J Biol Chem       Date:  2003-10-28       Impact factor: 5.157

View more
  25 in total

1.  Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives.

Authors:  David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.

Authors:  Heather E Moad; Augen A Pioszak
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

4.  N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Authors:  Sang-Min Lee; Jason M Booe; Joseph J Gingell; Virginie Sjoelund; Debbie L Hay; Augen A Pioszak
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

Review 5.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

Review 6.  Structure of Class B GPCRs: new horizons for drug discovery.

Authors:  Andrea Bortolato; Andrew S Doré; Kaspar Hollenstein; Benjamin G Tehan; Jonathan S Mason; Fiona H Marshall
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

7.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

8.  Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Authors:  Sang-Min Lee; Debbie L Hay; Augen A Pioszak
Journal:  J Biol Chem       Date:  2016-02-19       Impact factor: 5.157

Review 9.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 10.  Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Authors:  Rebekah L Bower; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2016-05-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.